دورية أكاديمية
826P Encorafenib and binimetinib followed by radiotherapy for patients with symptomatic BRAF mutated melanoma brain metastases: GEM1802/E-BRAIN clinical trial
| العنوان: | 826P Encorafenib and binimetinib followed by radiotherapy for patients with symptomatic BRAF mutated melanoma brain metastases: GEM1802/E-BRAIN clinical trial |
|---|---|
| المؤلفون: | Marquez-Rodas, I., Arance Fernandez, A.M., Berciano Guerrero, M.A., Garcia Castano, A., Alamo De La Gala, M.D.C., Gonzalez Cao, M., Sanchez Mauriño, P., Diaz Beveridge, R.P., Valduvieco, I., Delgado, R., Prada, P.J., Puertas, E., Romero, J.L., Conde, A., Alvarez, A., Berrocal, A. |
| المصدر: | Annals of Oncology ; volume 33, page S926 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2022 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2022.07.952 |
| الإتاحة: | https://doi.org/10.1016/j.annonc.2022.07.952Test https://api.elsevier.com/content/article/PII:S0923753422028034?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0923753422028034?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.D11E1078 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2022.07.952 |
|---|